Miura, Japan

Takaichi Shimozato

USPTO Granted Patents = 10 

 

Average Co-Inventor Count = 5.0

ph-index = 4

Forward Citations = 40(Granted Patents)


Location History:

  • Kanagawa, JP (2010)
  • Miura-shi, JP (2011)
  • Miura, JP (2004 - 2012)
  • Tokyo, JP (2021 - 2023)

Company Filing History:


Years Active: 2004-2023

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Takaichi Shimozato: Innovator in Pharmaceutical Antibodies

Introduction

Takaichi Shimozato is a prominent inventor based in Miura, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antibodies. With a total of 10 patents to his name, Shimozato's work has had a considerable impact on medical science.

Latest Patents

One of Shimozato's latest inventions is an anti-human TLR7 antibody. This pharmaceutical composition comprises an antibody that specifically binds to human TLR7 or monkey TLR7, while not binding to mouse TLR7 or rat TLR7. The invention is designed to inhibit the function of human TLR7 or monkey TLR7, showcasing its potential therapeutic applications.

Career Highlights

Throughout his career, Takaichi Shimozato has worked with notable companies in the pharmaceutical industry, including Sankyo Company, Limited and Daiichi Sankyo Company, Limited. His experience in these organizations has contributed to his expertise in antibody development and innovation.

Collaborations

Shimozato has collaborated with several professionals in his field, including Takahide Nishi and Futoshi Nara. These collaborations have likely enhanced his research and development efforts, leading to successful innovations.

Conclusion

Takaichi Shimozato is a distinguished inventor whose work in pharmaceutical antibodies has paved the way for advancements in medical treatments. His contributions continue to influence the field and inspire future innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…